Loading…
Shukra Pharmaceuticals (BSE 524632)₹55.87+0.25%Pharmaceuticals
At the end of the Sep 2026 quarter, Shukra Pharmaceuticals' shareholders were: promoters 51.11%, DIIs 0.11%, public 48.78%. Promoter holding is up 0.21 percentage points from 50.90% a quarter earlier. It had 28,398 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 51.11% |
| DIIs | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.99% | 48.78% |
| Number of shareholders | 10,968 | 12,980 | 14,996 | 16,329 | 17,853 | 18,240 | 20,347 | 21,452 | 25,662 | 27,186 | 28,398 | 28,398 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Renuka Yogesh Parikh | Public | 19.12% | −0.07 |
| Yogesh Biharilal Parikh | Public | 19.03% | −0.08 |
| Anar Project Private Limited | Promoter | 18.72% | −0.07 |
| Parshva Texchem India Private Ltd. | Promoter | 17.42% | +0.21 |
| Navkar Surgical Gujarat Limited | Promoter | 11.73% | −0.04 |
| Dakshesh Rameshchandra Shah | Promoter | 1.12% | +0.11 |
| Anar Jayeshbhai Patel | Promoter | 0.98% | −0.01 |
| Sujay Jyotindra Mehta | Promoter | 0.72% | 0.00 |
| Payal Sujay Mehta | Promoter | 0.52% | 0.00 |
Promoters held 51.11% of Shukra Pharmaceuticals at the end of the Sep 2026 quarter, up 0.21 percentage points from 50.90% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.11% (unchanged at 0.11% a quarter earlier).
Shukra Pharmaceuticals had 28,398 shareholders at the end of the Sep 2026 quarter, against 21,452 a year earlier.
Renuka Yogesh Parikh (Public) held 19.12% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.